Showing results (211-220 of 395) with videos related to
Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapyM Colleoni, G Viale, D Zahrieh, et al.Lancet (London, England)|May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study GroupC Hürny, J Bernhard, A S Coates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerMarco Colleoni, Bernard F Cole, Giuseppe Viale, et al.Breast Cancer Research and Treatment|December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experienceOtto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.American Journal of Obstetrics and Gynecology|February 26, 2004
Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316D Heather Watts, Rajalakshmi Balasubramanian, Robert T Maupin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIIIJürg Bernhard, David Zahrieh, Monica Castiglione-Gertsch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialB Ejlertsen, J Aldridge, K V Nielsen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.Breast Cancer Research and Treatment|October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trialsEvandro de Azambuja, Noam Ponde, Marion Procter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study GroupM Colleoni, M Bonetti, A S Coates, et al.Pageof 40